The International Finance Corporation (IFC), which owns equity stakes in many large commercial banks in emerging markets, is mulling an investment in Blue Sail Medical, a publicly-traded medical consumables manufacturer in China.
The World Bank Group’s private sector arm is considering the provision of a seven-year loan of up to $150 million to Blue Sail. The loan is subject to approval from IFC’s board of directors, and discussions around the proposal are expected to happen as early as March 3, the lending agency disclosed on Monday.
